Adaptimmune Therapeutics ADAPY
OTC ADAPY
$0.03 0.00 (-13.33%)
As of: Oct 21, 2026 · 12:27 PM EDT

Adaptimmune Therapeutics PLC (ADAPY) Debt Ratio (2024 - 2025)

Updated

Adaptimmune Therapeutics' (ADAPY) Debt Ratio came in at 0.20 for Q2 2025, up 153.4% from 0.08 a year earlier and up 22.3% from the prior quarter.

Analysis

Adaptimmune Therapeutics PLC (ADAPY) Debt Ratio (2024 - 2025) Analysis & Trends

Since Q2 2024, Adaptimmune Therapeutics has reported Debt Ratio for 5 quarters.

  • Quarterly Debt Ratio has run from a low of 0.08 in Q2 2024 to a high of 0.20 in Q4 2024 over five years.
  • According to Business Quant data, Debt Ratio for the three prior quarters was 0.16 (Q1 2025), 0.20 (Q4 2024) and 0.16 (Q3 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 0.20
Mar 31, 2025 0.16
Dec 31, 2024 0.20
Sep 30, 2024 0.16
Jun 30, 2024 0.08
API Access

Adaptimmune Therapeutics PLC Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=ADAPY&period=max&api_key=YOUR_API_KEY